A Multicenter, Open Label, Expanded Access Trial Of Maraviroc
A Multicenter, Open Label, Expanded Access Trial Of Maraviroc
To provide access to maraviroc to patients who have limited or no therapeutic treatment options and to collect more safety data in a broader patient population.
Inclusion Criteria:
Exclusion Criteria:
Los Angeles, California 90033, United States
Manhasset, New York 11030, United States
Stanton Island, New York 10304, United States
Annandale, Virginia 22003, United States
A-1090, Austria
Barrio Aranjuez, Provincia de San José, Costa Rica
Dresden, 01307, Germany
Hanover, 30625, Germany
Mumbai, Maharashtra 400 026, India
Genova, 16132, Italy
Modena, 41100, Italy
Torrette Di Ancona, 60121, Italy
Tlalpan, Mexico Df CP 14000, Mexico
Lisbon, 1169-050, Portugal
Basurto, Bilbao 48078, Spain
Santiago de Compostela, La Coruña 15706, Spain
Kaohsiung County, 824, Taiwan
Brighton, Sussex BN2 1ES, United Kingdom
Crumpsall, Manchester, M8 6RB, United Kingdom